The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors.

@article{Schrader2003TheAS,
  title={The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors.},
  author={Joachim Schrader and Stephan Lueders and Anke Kulschewski and J{\"u}rgen R. Berger and Walter Zidek and Johannes Treib and Karl Einh{\"a}upl and Hans Christoph Diener and Peter Dominiak},
  journal={Stroke},
  year={2003},
  volume={34 7},
  pages={
          1699-703
        }
}
BACKGROUND AND PURPOSE The Acute Candesartan Cilexetil Therapy in Stroke Survivors (ACCESS) study was designed to assess the safety of modest blood pressure reduction by candesartan cilexetil in the early treatment of stroke. The study was also designed to provide an estimate of the number of cases required to perform a larger phase III efficacy study. METHODS Five hundred patients were recruited in a prospective, double-blind, placebo-controlled, randomized, multicenter phase II study… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 207 CITATIONS

FILTER CITATIONS BY YEAR

2003
2018

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 8 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 18 REFERENCES

Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats

  • Y Inada, T Wada, +6 authors K. Nishikawa
  • Clin Exp Hypertens
  • 1997

The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology . Acute myocardial infarction : pre - hospital and in - hospital management

  • CE Mogensen
  • Eur Heart J
  • 1996

Hochdruck und zerebrale Durchblutungsstörungen

  • Deutsche Hochdruckliga
  • Deutsche Hochdruckliga. Heidelberg,
  • 1995

Similar Papers

Loading similar papers…